stockportfolio.pro logostockportfolio.pro
Stocks Screener Start 7-day free trial
Stocks / ABT / Revenue

Abbott Laboratories Revenue 2007–2025

Abbott Laboratories (ABT) annual revenue by fiscal year, computed from SEC filings. Compound growth +3.0%/yr over 18 years.

Fiscal yearRevenueChange (YoY)
FY 2025$44.33B+5.7%
FY 2024$41.95B+4.6%
FY 2023$40.11B-8.1%
FY 2022$43.65B+1.3%
FY 2021$43.08B+24.5%
FY 2020$34.61B+8.5%
FY 2019$31.90B+4.3%
FY 2018$30.58B+11.6%
FY 2017$27.39B+31.3%
FY 2016$20.85B+2.2%
FY 2015$20.41B+0.8%
FY 2014$20.25B+3.0%
FY 2013$19.66B+3.2%
FY 2012$19.05B-11.0%
FY 2011$21.41B-39.1%
FY 2010$35.17B+14.3%
FY 2009$30.76B+4.2%
FY 2008$29.53B+13.9%
FY 2007$25.91B

Source: Abbott Laboratories SEC filings — income statement (10-K). Refreshed nightly.

See the full picture for Abbott Laboratories

Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.

Open the interactive view — free

Abbott Laboratories — frequently asked questions

What is Abbott Laboratories's revenue?

Abbott Laboratories (ABT) reported revenue of $44.33B for fiscal year 2025, per its SEC filings.

How has Abbott Laboratories's revenue changed over time?

Between fiscal 2007 and 2025, ABT's revenue grew at roughly 3.0% per year (compound annual rate), from $25.91B to $44.33B.

Where does this data come from?

Figures are computed from Abbott Laboratories's official SEC filings (income statement (10-K)), refreshed nightly. Not investment advice.

More ABT financial history

Full ABT fundamentals page → · All 1,500+ companies →